Population
663 patients with a first unprovoked venous thromboembolic event (VTE), multi-national.
Design
Cohort, blinded adjudication of outcomes
Follow-up
mean 5.0 years
Authors
Loading...
May support risk-stratified indefinite anticoagulation after unprovoked VTE; leaves open randomized trials to confirm thresholds.
Men and high-risk women have a high long-term risk of recurrent VTE after a first unprovoked event and should be considered for indefinite anticoagulation, whereas low-risk women may safely discontinue therapy.
Rodger et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: